Continuous Facial Myokymia in Multiple Sclerosis: Treatment with Botulinum Toxin

Publisher： Karger

E-ISSN： 1421-9913|43|3|137-140

ISSN： 0014-3022

Source： European Neurology, Vol.43, Iss.3, 2000-04, pp. : 137-140

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Low-Dose Treatment of Cervical Dystonia, Blepharospasm and Facial Hemispasm with Albumin-Diluted Botulinum Toxin Type A under EMG Guidance

By  

European Neurology, Vol. 43, Iss. 1, 2000-01 ,pp. : 9-12

Karger

Access to resources Recommend Favorite

Use of Botulinum Toxin in the Treatment of Achalasia

By  

Digestive Diseases, Vol. 16, Iss. 1, 1998-02 ,pp. : 14-22

Karger

Access to resources Recommend Favorite

Botulinum Toxin in the Treatment of Lingual Dystonia Induced by Speaking

By  

Case Reports in Neurology, Vol. 5, Iss. 1, 2013-01 ,pp. : 18-20

Karger

Access to resources Recommend Favorite

Symptomatic Treatment of Multiple Sclerosis

By  

European Neurology, Vol. 56, Iss. 2, 2006-09 ,pp. : 78-105

Karger

Access to resources Recommend Favorite

REVIEW: The Use of Botulinum Toxin for the Treatment of Gastrointestinal Motility Disorders

By Friedenberg Frank   Gollamudi Satya   Parkman Henry P.  

Digestive Diseases and Sciences, Vol. 49, Iss. 2, 2004-02 ,pp. : 165-175

Springer Publishing Company

Access to resources Recommend Favorite